These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38124888)

  • 1. Preventive effect and mechanism of compound Danshen dripping pills on contrast-induced nephropathy after percutaneous coronary interventional.
    Fu H; Wang L; Ying S; Zhao Z; Zhang P
    Front Cardiovasc Med; 2023; 10():1211982. PubMed ID: 38124888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of probucol on preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention].
    Suo XQ; Yang SC; Ma ZH; Sun TT; Zhang WY; Cong HL; Lin WH; Lu CZ; Tian FS; Fu NK
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(41):3234-3238. PubMed ID: 29141361
    [No Abstract]   [Full Text] [Related]  

  • 3. Compound danshen dripping pill pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Yang R; Chang L; Guo BY; Wang YW; Wang YL; Jin X; Liu SY; Li YJ
    Evid Based Complement Alternat Med; 2014; 2014():256268. PubMed ID: 25386219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Compound Danshen Dripping Pills on Ventricular Remodeling and Cardiac Function after Acute Anterior Wall ST-Segment Elevation Myocardial Infarction (CODE-AAMI): Protocol for a Randomized Placebo-Controlled Trial.
    Wu YJ; Deng B; Wang SB; Qiao R; Zhang XW; Lu Y; Wang L; Gu SZ; Zhang YQ; Li KQ; Yu ZL; Wu LX; Zhao SB; Zhou SL; Yang Y; Wang LS
    Chin J Integr Med; 2023 Dec; 29(12):1059-1065. PubMed ID: 37656413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of probucol combined with hydration in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention: a multicenter, prospective, randomized controlled study.
    Fu N; Yang S; Zhang J; Zhang P; Liang M; Cong H; Lin W; Tian F; Lu C
    Int Urol Nephrol; 2018 Jan; 50(1):105-112. PubMed ID: 29071556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term compound danshen dripping pills therapy reduces the no-reflow phenomenon in nondiabetes mellitus patients after primary percutaneous coronary intervention for acute myocardial infarction.
    A X; Li Z; Luo W; Chai J
    Ann Palliat Med; 2020 May; 9(3):1144-1151. PubMed ID: 32498529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of INtensive Treatment vs. Standard Treatment of COmpound DanshEn Dripping Pills in Refractory Angina Patients With Incomplete Revascularization (INCODER Study): Study Protocol for a Multicenter, Double-Blind, Randomized Controlled, Superiority Trial.
    Wu Z; Xu D; Wu Z; Chen A; Liu L; Ling L; Zhou Y; Liu D; Liu Y; Dong Y; Chen Y
    Front Cardiovasc Med; 2022; 9():860059. PubMed ID: 35557513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
    Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
    Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of intravenous transplantation of human umbilical cord blood mononuclear cells combined compound Danshen dripping pills on the microenvironment and apoptosis in the myocardium of the rabbits with acute myocardial infarction].
    Yuan C; Ai Q; Deng L; Yu G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 38(8):785-92. PubMed ID: 23981987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prophylactic effect of alprostadil on contrast-induced nephropathy in renal insufficiency patients after percutaneous coronary intervention.
    Liu D; Gao F; Li L; Jian X; Xiao B
    Am J Transl Res; 2021; 13(4):3766-3772. PubMed ID: 34017563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meta-analysis of effect of Qishen Yiqi Dripping Pills combined with Western medicine on adverse cardiovascular events and quality of life after percutaneous coronary intervention].
    Dai QQ; Shi ZF; Hu JY; Han SJ; Zhong CM; Guan MK; Tian GH; Shang HC
    Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(6):1498-1510. PubMed ID: 33787149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.
    Liang M; Yang S; Fu N; Lu C; Tian F; Xing X; Lin W; Liu J
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):742-750. PubMed ID: 29024304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Vigileo/FloTrac System-Guided Aggressive Hydration in Acute Myocardial Infarction Patients to Prevent Contrast-Induced Nephropathy After Urgent Percutaneous Coronary Intervention.
    Ling W; Jiang Z; Liu K; Zhang H; Qian Y; Tian J; Zhang Z; Chen Y; Qian G
    Am J Cardiol; 2023 May; 195():77-82. PubMed ID: 37018968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain natriuretic peptide for prevention of contrast-induced nephropathy after percutaneous coronary intervention or coronary angiography.
    Liu JM; Xie YN; Gao ZH; Zu XG; Li YJ; Hao YM; Chang L
    Can J Cardiol; 2014 Dec; 30(12):1607-12. PubMed ID: 25418218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of urinary neutrophil gelatinase-associated lipocalin for early diagnosis of contrast-induced nephropathy].
    You W; Qi CL; Ye F; Huang SL; Xie DJ; Wu ZM; Huang K; Chen KL; Huang TY; Chen SL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Dec; 44(12):1024-1029. PubMed ID: 28056233
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of double-dose vs. usual dose of nicorandil for the prevention of contrast-induced nephropathy after cardiac catheterization.
    Zeng Z; Fu X; Zhang X; Fu N
    Int Urol Nephrol; 2019 Nov; 51(11):1999-2004. PubMed ID: 31385178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic Acid Attenuates Contrast-Induced Nephropathy in Patients With Hyperhomocysteinemia Undergoing Coronary Catheterization: A Randomized Controlled Trial.
    Peng L; Shui X; Tan F; Li Z; Ling Y; Wu B; Chen L; Li S; Peng H
    Front Cardiovasc Med; 2021; 8():707328. PubMed ID: 34660712
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma neutrophil gelatinase-associated lipocalin (NGAL) as an early predictive marker of contrast-induced nephropathy in hospitalized patients undergoing computed tomography.
    Filiopoulos V; Biblaki D; Lazarou D; Chrisis D; Fatourou M; Lafoyianni S; Vlassopoulos D
    Clin Kidney J; 2013 Dec; 6(6):578-83. PubMed ID: 26069825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different hydration methods for the prevention of contrast-induced nephropathy in patients with elective percutaneous coronary intervention: a retrospective study.
    Chen F; Lu J; Yang X; Liu D; Wang Q; Geng X; Xiao B; Zhang J; Liu F; Gu G; Cui W
    BMC Cardiovasc Disord; 2023 Jun; 23(1):323. PubMed ID: 37355592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.